Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden.
Haematologica. 2013 Sep;98(9):1424-32. doi: 10.3324/haematol.2013.085852. Epub 2013 May 3.
Between 1992 and 2008, 713 high hyperdiploid acute lymphoblastic leukemias in children aged 1-15 years were diagnosed and treated according to the Nordic Society for Pediatric Hematology and Oncology acute lymphoblastic leukemia 1992/2000 protocols. Twenty (2.8%) harbored t(1;19), t(9;22), der(11q23), or t(12;21). The median age of patients with "classic" high hyperdiploidy was lower than that of patients with translocation-positive high hyperdiploidy (P<0.001). Cases with triple trisomies (+4, +10, +17), comprising 50%, had higher modal numbers than the triple trisomy-negative cases (P<0.0001). The probabilities of event-free survival and overall survival were lower for those with white blood cell counts ≥ 50 × 10(9)/L (P=0.017/P=0.009), ≥ 5% bone marrow blasts at day 29 (P=0.001/0.002), and for high-risk patients (P<0.001/P=0.003), whereas event-free, but not overall, survival, was higher for cases with gains of chromosomes 4 (P<0.0001), 6 (P<0.003), 17 (P=0.010), 18 (P=0.049), and 22 (P=0.040), triple trisomies (P=0.002), and modal numbers >53/55 (P=0.020/0.024). In multivariate analyses, modal number and triple trisomies were significantly associated with superior event-free survival in separate analyses with age and white blood cell counts. When including both modal numbers and triple trisomies, only low white blood cell counts were significantly associated with superior event-free survival (P=0.009). We conclude that high modal chromosome numbers and triple trisomies are highly correlated prognostic factors and that these two parameters identify the same subgroup of patients characterized by a particularly favorable outcome.
1992 年至 2008 年间,诊断并治疗了 713 例年龄在 1-15 岁的高倍体急性淋巴细胞白血病患儿,这些患儿依据北欧儿科血液学和肿瘤学协会急性淋巴细胞白血病 1992/2000 方案治疗。其中 20 例(2.8%)存在 t(1;19)、t(9;22)、der(11q23)或 t(12;21)。经典高倍体性患者的中位年龄低于染色体易位阳性高倍体性患者(P<0.001)。三三体(+4、+10、+17)占 50%的病例,其模式数高于三三体阴性病例(P<0.0001)。白细胞计数≥50×10(9)/L(P=0.017/P=0.009)、29 天骨髓原始细胞≥5%(P=0.001/0.002)和高危患者(P<0.001/P=0.003)的无事件生存率和总生存率较低,而染色体 4(P<0.0001)、6(P<0.003)、17(P=0.010)、18(P=0.049)和 22(P=0.040)获得、三倍三体(P=0.002)和模式数>53/55(P=0.020/0.024)的病例无事件生存率较高。多变量分析显示,在分别与年龄和白细胞计数进行的分析中,模式数和三倍三体与无事件生存率显著相关。当同时包括模式数和三倍三体时,只有白细胞计数低与无事件生存率显著相关(P=0.009)。我们得出结论,高模式染色体数和三倍三体是高度相关的预后因素,这两个参数确定了具有特别有利结局的同一亚组患者。